147 results
424B3
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement
4:53pm
or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons … of this prospectus (as it may be supplemented or amended from time to time) available to the Selling Stockholders for the purpose of satisfying the prospectus
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed
8-K
EX-4.2
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.
“Securities Act … of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value
8-K
EX-4.3
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose … and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the board of directors of the Company … or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, and (D
8-K
EX-4.1
51a65algsozo2
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
DEF 14C
xm9gs 15llr
18 Mar 24
Information statement
4:59pm
PRE 14C
kkzx8090ha27dy0xvp6
8 Mar 24
Preliminary information
4:31pm
424B3
gltrso2lp0 cl2
2 Feb 24
Prospectus supplement
12:00am
DEF 14C
pfeoeqc g6
29 Jan 24
Information statement
8:00am
PRE 14C
fqeb0hjvoiaqtj fhal
17 Jan 24
Preliminary information
5:05pm
8-K
EX-10.1
lkm4k5yi
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.1
e6lxoxhwbt0f6a3v
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.2
zc1qsy6268toxfg3
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm